Crescenta Biosciences Inc. is a biotechnology startup founded in 2015. The company focuses on small molecule drug discovery with a novel therapeutic approach for diseases related to fatty acid metabolism. Crescenta's unique discovery platform allows the manipulation of biological functions associated with "fatty acid interacting proteins" to correct metabolic imbalances, offering broad therapeutic opportunities. With a portfolio of first-in-class drug candidates, Crescenta aims to address diseases with major unmet medical needs, particularly those related to metabolism and aging. The company's ultimate goal is to advance its pipeline into clinical development and commercialization, positioning itself as a promising player in the biotechnology industry.
There is no investment information
No recent news or press coverage available for Crescenta Biosciences Inc. .
We care about your data, and we'd love to use cookies make your experience better.
